LY2189102
LY2189102 is a humanized monoclonal antibody inhibitor targeting interleukin-1β (IL-1β) . LY2189102 is promising for research of type 2 diabetes[1].
Product Specifications
UNSPSC
12352203
Target
Interleukin Related
Related Pathways
Immunology/Inflammation
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Smiles
[LY2189102]
References & Citations
[1]Sloan-Lancaster J, et al. Double-blind, randomized study evaluating the glycemic and anti-inflammatory effects of subcutaneous LY2189102, a neutralizing IL-1β antibody, in patients with type 2 diabetes. Diabetes Care. 2013 Aug;36 (8) :2239-46.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Isoform
IL-1
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS456974-01 48 Tests
Human Actin Related Protein 2/3 Complex Subunit 4 (ARPC4) ELISA Kit
Ask
View Details MBS456974-02 96 Tests
Human Actin Related Protein 2/3 Complex Subunit 4 (ARPC4) ELISA Kit
Ask
View Details 
MBS456974-03 5x 96 Tests
Human Actin Related Protein 2/3 Complex Subunit 4 (ARPC4) ELISA Kit
Ask
View Details MBS456974-04 10x 96 Tests
Human Actin Related Protein 2/3 Complex Subunit 4 (ARPC4) ELISA Kit
Ask
View Details 